Living Medical Textbook - Neurology - Projects In Knowledge - Multiple Sclerosis Edition - Insights into Managing Multiple Sclerosis Table of Contents - Multiple Sclerosis Basics CME Information

Chapter 1 – Multiple Sclerosis Basics

Editor-In-Chief
	Bruce A. Cohen, MD Professor Davee Department of Neurology Feinberg School of Medicine Northwestern University Chicago, Illinois
Contributing Editor
	Scott S. Zamvil, MD, PhD Associate Professor Department of Neurology Program in Immunology University of California, San Francisco San Francisco, California
top

Activity Goal
The goal of this CME/CE activity is to examine the pathophysiology, etiologic factors, classification, and diagnostic criteria of multiple sclerosis.

Target Audience
This CME/CE activity is designed for neurologists, internal medicine specialists, family practice/primary care physicians, nurse specialists/nurse practitioners, physician assistants, and other health professionals who interact with and are involved in the management and treatment of patients with multiple sclerosis.

Learning Objectives

•	Analyze the contributions of proposed etiologies and pathogenetic processes in MS based on current data in order to appropriately counsel patients and form the basis of an understanding of potential therapeutic targets.
•	Diagnose and classify MS in patients with neurologic symptoms, using clinical, radiologic, and other tools, in accordance with the modified McDonald Criteria.

top

CME Information: Physicians
Statement of Accreditation
Projects In Knowledge^® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Projects In Knowledge designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CE Information: Nurses
Projects In Knowledge^® (PIK) is an approved provider of continuing nursing education by the Delaware Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. PIK provider code: 080903-PROV.

Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227.

This activity is approved for 1.23 nursing contact hour(s).

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, DNA, CBRN, or PIK endorsement of any commercial product or service.

CE Information: Pharmacists

Projects In Knowledge^® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This chapter is worth up to 2.00 contact hours (0.2 CEUs). The ACPE Universal Program Number assigned to this knowledge activity is 0052-0000-09-066-H01P.

top

Disclosure Information
The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Bruce A. Cohen, MD, has received honoraria and participated in speakers bureaus of Bayer Pharmaceuticals, Biogen-Idec, EMD-Serono, and Teva Neuroscience; has received consulting fees from Accorda Pharmaceuticals, Astellis, Bayer Pharmaceuticals, Biogen-Idec, EMD-Serono, Sanofi-Aventis, and Teva Neuroscience; and has ownership interest in Abbott Laboratories and CVS-Caremark.

Scott S. Zamvil, MD, PhD, has received grant/research support from the NIH, the National Multiple Sclerosis Society, and Teva Pharmaceuticals; and has received honorarium and is on the advisory boards of Biogen Idec and Teva Pharmaceuticals.

Lauren A. Cerruto has no significant relationships to disclose.

Off-Label Discussion: This activity will not contain a discussion of unlabeled/unapproved or investigational uses of MS therapies.

Peer Reviewer has disclosed no significant relationships.

Projects In Knowledge’s staff members have no significant relationships to disclose.

top

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

Contract for Mutual Responsibility in CME/CE

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

top

1876.01